Brief news reports on Tuberculosis

Huge protest march at AIDS 2012 ends in 12 arrests

25 July 2012 - Washington, DC - TB/HIV activist Mark Harrington, who is TAG’s Executive Director, and 11 others were arrested yesterday by U.S. Park Police when they held a civil disobedience outside the White House. The arrest came after they began tying hundreds of pouches of medicine and dollar bills tied with red ribbon to symbolize their call for more funding for antiretroviral treatment. As the 12 were arrested, hundreds chanted from behind barricades: "The whole world is watching! The whole world is watching!"

Read More →

SQ109 to be evaluated for efficacy on multi-drug resistant patients

Maxwell Biotech Venture Fund’s portfolio company, Infectex, receives Russian regulator’s approval to conduct pivotal clinical trial for Sequella’s antibiotic, SQ109, for tuberculosis.

Read More →

Let's learn from HIV activists how to achieve zero tuberculosis deaths

The International AIDS Conference is gathering thousands of people, from patients to researchers to activists, to achieve nothing less than an "end to the HIV epidemic." And although the epidemic is still claiming way too many lives, recent advances in research, treatment, and prevention have been nothing but phenomenal. As someone who has been fighting another deadly scourge, tuberculosis (TB), for more than 15 years, I find myself wondering: what can we learn from HIV activists?

Read More →

Streptomycin regimen will no longer be used in South African province

Termination of the use of streptomycin for re-treatment cases.

Read More →

TB: Cost of inaction increases from $25 to $500,000

Well, that is the difference of cost in treating a simple tuberculosis (drug susceptible TB) patient to the one suffering from drug resistant TB (DR TB) according to Lucica Ditiu, Executive Secretary of The Stop TB Partnership, who made a fervent appeal for ending tuberculosis and called for zero TB and HIV deaths, while appearing on a live web-cast talk show on ‘tuberculosis and HIV: protecting the vulnerable women and children’ presented by The Stop TB Partnership and the International Federation of Red Cross and Red Crescent Societies (IFRC) during the XIX International AIDS Conference in Washington DC. She was optimistic that just by scaling up the existing tools and services in TB we can save one million lives by 2015.

Read More →

To attack HIV and AIDS, put an end to TB

More than 20,000 activists, health experts and global leaders from nearly every nation are in Washington this week for the 19th International AIDS Conference.

Read More →

Nasopharyngeal specimens allow pulmonary TB diagnosis in children

When induced sputum and culture are not available, nasopharyngeal specimens may be used for rapid molecular diagnosis of pulmonary tuberculosis in children, a new study shows.

Read More →

Efavirenz works in kids with both HIV and TB

Children coinfected with HIV and tuberculosis appear to suppress both infections when treated with standard TB regimens and an efavirenz-based HIV regimen, researchers said here at the International AIDS Conference.

Read More →

Antiretroviral therapy for prevention of tuberculosis in adults with HIV: A systematic review and meta-analysis

Antiretroviral therapy is strongly associated with a reduction in the incidence of tuberculosis across all CD4 count strata. Earlier initiation of antiretroviral therapy may be a key component of global and national strategies to control the HIV-associated tuberculosis syndemic.

Read More →

MSF: First-ever study of HIV treatment policies in 23 countries

The study looks at 25 indicators in each country, ranging from coverage of ART and prevention of mother-to-child transmission, to whether nurses instead of doctors can start patients on HIV and TB treatment.

Read More →

Page 503 of 580 · Total posts: 10

←First 502 503 504 Last→